ImmunologybioRxiv
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
A. E. Chaouat, H. Achdout, I. Kol…·O. Mandelboim
This paper develops RBD-Ig fusion proteins that efficiently neutralize SARS-CoV-2 infection in vitro and in vivo, outperforming ACE2-Ig.
DOI 10.1371/journal.ppat.1010175